SONN
Price:
$0.8715
Market Cap:
$4.53M
Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead candidate is SON-1010, a fully human version of interleukin 12 for the treatment non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6 for chemotherapy-induced peripheral neuropathy and diabetic peripheral neuropathy. It has a license agreeme...[Read more]
Industry
Biotechnology
IPO Date
2006-10-31
Stock Exchange
NASDAQ
Ticker
SONN
According to Sonnet BioTherapeutics Holdings, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -7.26. This represents a change of -848.47% compared to the average of 0.97 of the last 4 quarters.
The mean historical PE Ratio of Sonnet BioTherapeutics Holdings, Inc. over the last ten years is -0.73. The current -7.26 PE Ratio has changed 99.73% with respect to the historical average. Over the past ten years (40 quarters), SONN's PE Ratio was at its highest in in the March 2024 quarter at 5.97. The PE Ratio was at its lowest in in the March 2019 quarter at -10.76.
Average
-0.73
Median
-0.72
Minimum
-1.88
Maximum
0
Discovering the peaks and valleys of Sonnet BioTherapeutics Holdings, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 50.67%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -1.88
Year | PE Ratio | Change |
---|---|---|
2023 | -0.16 | -26.23% |
2022 | -0.21 | -64.18% |
2021 | -0.60 | -23.17% |
2020 | -0.78 | -21.91% |
2019 | -1.00 | 50.67% |
2018 | -0.66 | -32.22% |
2017 | -0.98 | -2.64% |
2016 | -1.00 | -46.60% |
2015 | -1.88 | -Infinity% |
2014 | 0 | -100.00% |
The current PE Ratio of Sonnet BioTherapeutics Holdings, Inc. (SONN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-0.32
5-year avg
-0.55
10-year avg
-0.73
Sonnet BioTherapeutics Holdings, Inc.’s PE Ratio is less than YS Biopharma Co., Ltd. (0), less than ZyVersa Therapeutics, Inc. (-2.20), less than Allarity Therapeutics, Inc. (-0.10), less than Kiromic BioPharma, Inc. (-0.19), less than Immix Biopharma, Inc. (-0.14), less than CNS Pharmaceuticals, Inc. (-2.98), less than eFFECTOR Therapeutics, Inc. (-0.00), less than Navidea Biopharmaceuticals, Inc. (-0.00), less than null (0.03),
Company | PE Ratio | Market cap |
---|---|---|
0 | $192.09M | |
-2.20 | $2.70M | |
-0.10 | $7.01M | |
-0.19 | $3.14M | |
-0.14 | $54.08M | |
-2.98 | $4.60M | |
-0.00 | $188.18K | |
-0.00 | $100.08K | |
0.03 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sonnet BioTherapeutics Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sonnet BioTherapeutics Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Sonnet BioTherapeutics Holdings, Inc.'s PE Ratio?
How is the PE Ratio calculated for Sonnet BioTherapeutics Holdings, Inc. (SONN)?
What is the highest PE Ratio for Sonnet BioTherapeutics Holdings, Inc. (SONN)?
What is the 3-year average PE Ratio for Sonnet BioTherapeutics Holdings, Inc. (SONN)?
What is the 5-year average PE Ratio for Sonnet BioTherapeutics Holdings, Inc. (SONN)?
How does the current PE Ratio for Sonnet BioTherapeutics Holdings, Inc. (SONN) compare to its historical average?